Large-Joint Reconstructive Implants | US | 2018 | Market Analysis

Demand for better patient outcomes will drive the uptake of surgical assistance and manufacturing technologies, supporting the expansion of the US large-joint reconstructive implant market; however, downward pricing pressure, partially driven by bundled payment initiatives such as the CJR model, will limit overall market potential, even as favorable demographic trends support modest procedure volume growth.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for large-joint reconstructive implants in the US across a 10-year period.

The implementation of bundled payment models such as the CJR model will heavily influence the large-joint reconstructive implant market in the US throughout the forecast period.

How will physician treatment practices change in response to bundled payment models?

How will procedure mix, procedure volumes, and ASPs be affected by bundled payment models?

How will the potential changes to the CJR model affect the market going forward?

As the market shifts toward value-based incentives, health care providers and orthopedic manufacturers are adopting new strategies to improve patient outcomes based on total episodes of care.

What are the current purchasing priorities of health care facilities?

How are health care facilities adding value to preoperative and postoperative care?

What strategies and added services are orthopedic manufacturers adopting in response to shifting hospital demands?

Technological innovation will have a significant impact on the US large-joint reconstruction market.

What are the potential benefits of additive manufacturing and how will it affect the adoption of certain implants?

How are companies reacting to the trends surrounding robotic assistance and navigation technologies?

What are some emerging products that can potentially create market share shifts?